tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MIST Stock Latest News

Milestone partner announces Phase 3 study of etripamil met primary endpoint
The FlyMilestone partner announces Phase 3 study of etripamil met primary endpoint
2M ago
MIST
Milestone Pharmaceuticals Welcomes New Directors and Auditor
PremiumCompany Announcements
Milestone Pharmaceuticals Welcomes New Directors and Auditor
2M ago
8K
MIST
Milestone Pharmaceuticals appoints Joseph Papa to board of directors
PremiumThe Fly
Milestone Pharmaceuticals appoints Joseph Papa to board of directors
2M ago
MIST
Milestone Pharmaceuticals initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Milestone Pharmaceuticals initiated with a Buy at Rodman & Renshaw
2M ago
MIST
Milestone Pharmaceuticals’ Promising Drug Advancements
PremiumCompany Announcements
Milestone Pharmaceuticals’ Promising Drug Advancements
3M ago
MIST
Milestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
PremiumCompany AnnouncementsMilestone Pharmaceuticals Eyes 2025 for CARDAMYST Launch
3M ago
MIST
Milestone Pharmaceuticals reports Q2 EPS (14c), consensus (19c)
Premium
The Fly
Milestone Pharmaceuticals reports Q2 EPS (14c), consensus (19c)
3M ago
MIST
Milestone Pharmaceuticals Bolsters Board with New Directors
Premium
Company Announcements
Milestone Pharmaceuticals Bolsters Board with New Directors
4M ago
MIST
Milestone Pharmaceuticals appoints Duty, Saik to board of directors
PremiumThe Fly
Milestone Pharmaceuticals appoints Duty, Saik to board of directors
4M ago
ARVN
MIST
Milestone Pharmaceuticals announces FDA acceptance of NDA for CARDAMYST
PremiumThe Fly
Milestone Pharmaceuticals announces FDA acceptance of NDA for CARDAMYST
5M ago
MIST
Milestone Pharmaceuticals partners with Arrhythmia Alliance on SVT awareness
PremiumThe Fly
Milestone Pharmaceuticals partners with Arrhythmia Alliance on SVT awareness
5M ago
MIST
Milestone Pharmaceuticals Excels with New Drug Update
PremiumCompany Announcements
Milestone Pharmaceuticals Excels with New Drug Update
6M ago
MIST
Milestone Pharmaceuticals reports Q1 EPS (21c), consensus (26c)
PremiumThe FlyMilestone Pharmaceuticals reports Q1 EPS (21c), consensus (26c)
6M ago
MIST
Is MIST a Buy, Before Earnings?
Premium
Pre-Earnings
Is MIST a Buy, Before Earnings?
6M ago
MIST
Milestone’s Etripamil Shows Promise in Self-Managed PSVT Treatment
Premium
Company Announcements
Milestone’s Etripamil Shows Promise in Self-Managed PSVT Treatment
7M ago
MIST
Milestone: Etripamil ‘effective’ at restoring sinus rhythm in trial
PremiumThe Fly
Milestone: Etripamil ‘effective’ at restoring sinus rhythm in trial
7M ago
MIST
Milestone’s Etripamil Aims to Revolutionize PSVT Treatment
PremiumCompany Announcements
Milestone’s Etripamil Aims to Revolutionize PSVT Treatment
7M ago
MIST
Milestone Pharmaceuticals announces resubmission of NDA for etripamil
PremiumThe Fly
Milestone Pharmaceuticals announces resubmission of NDA for etripamil
7M ago
MIST
Milestone Pharmaceuticals Advances Etripamil Development
PremiumCompany Announcements
Milestone Pharmaceuticals Advances Etripamil Development
8M ago
MIST
Milestone Pharmaceuticals reports FY23 EPS ($1.39), consensus ($1.37)
PremiumThe FlyMilestone Pharmaceuticals reports FY23 EPS ($1.39), consensus ($1.37)
8M ago
MIST
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
8M ago
ALT
CTMX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
8M ago
ALT
CTMX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >